Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class a scavenger receptor (SR-A)

Diabetologia

Volumn 48, Issue 2, 2005, Pages 317-327

  Nakajou, K ^a   Horiuchi, S ^b   Sakai, M ^b   Haraguchi, N ^a   Tanaka, M ^b   Takeya, M ^b   Otagiri, M ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AGE; Biological fate; Diabetic nephropathy; Endocytosis; Intermediate aldehydes; Scavenger receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ISOLATION; DIABETIC NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; KIDNEY CLEARANCE; KNOCKOUT MOUSE; LIVER CLEARANCE; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

ACETALDEHYDE; ACTINS; ANIMALS; AREA UNDER CURVE; FACTOR VIII; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; KERATINS; METABOLIC CLEARANCE RATE; MICE; PROTEINS; PYRUVALDEHYDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS A; SERUM ALBUMIN, BOVINE; VIMENTIN;

EID: 17444380766     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1646-6     Document Type: Article

References (38)

1. Maillard LC (1912) Action des acids amines sur les sucres: formation des melanoidines par voie methodique. C R Acad Sci (Paris) 154:66-68
2. Horiuchi S, Higashi T, Ikeda K et al (1996) Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes 45:73-76
3. Nagai R, Matsumoto K, Ling X, Suzuki H, Araki T, Horiuchi S (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49:1714-1723
4. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW (1995) Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34: 3702-3709
5. Nagai R, Hayashi CM, Xia L, Takeya M, Horiuchi S (2002) Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 277:48905-48912
6. Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS (1999) Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48:198-202
7. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y (2000) Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 6: 114-125
8. Tanji N, Markowitz GS, Fu C et al (2000) Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11:1656-1666
9. Sugiyama S, Miyata T, Horie K et al (1996) Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant 11:91-94
10. Lal MA, Brismar H, Eklof AC, Aperia A (2002) Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 61:2006-2014
11. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1992) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A 89:2873-2877
12. Pugliese G, Pricci F, Romeo G et al (1997) Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46:1881-1887
13. Kim YS, Kim BC, Song CY, Hong HK, Moon KC, Lee HS (2001) Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-β. J Lab Clin Med 138:59-68
14. Yamagishi S, Inagaki Y, Okamoto T et al (2002) Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277:20309-20315
15. Neeper M, Schmidt AM, Brett J et al (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004
16. Li YM, Mitsuhashi T, Wojciechowicz D et al (1996) Molecular identity and cellular distribution of advanced glycation end-product receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A 93: 11047-11052
17. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M (1990) Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343: 531-535
18. Ohgami N, Nagai R, Ikemoto M et al (2001) CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 276:3195-3202
19. Ohgami N, Nagai R, Miyazaki A et al (2001) Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem 276:13348-13355
20. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S (2002) Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 511:170-174
21. Takemura T, Yoshioka K, Aya N et al (1993) Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927
22. He CJ, Zheng F, Stitt A, Striker L, Hattori M, Vlassara H (2000) Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. Kidney Int 58:1931-1940
23. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D (1994) Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528
24. Suzuki H, Kurihara Y, Takeya M et al (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296
25. Sakai M, Miyazaki A, Hakamata H et al (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 269:31430-31435
26. Hnatowich DJ, Layne WW, Childs RL (1982) The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isot 33:327-332
27. 125I: effect of labeling on distribution and excretion of radioactivity in rats. J Pharm Sci 88:577-585
28. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879-885
29. Isobe Y, Nakane PK, Brown WR (1977) Studies on translocation of immunoglobulins across intestinal epithelium, I: improvements in the peroxidase-labeled antibody method for application to study of human intestinal mucosa. Acta Histochem Cytochem 10:161-171
30. Mori T, Bartocci A, Satriano J et al (1990) Mouse mesangial cells produce colony-stimulating factor-1 (CSF-1) and express the CSF-1 receptor. J Immunol 144:4697-4702
31. Kasho M, Sakai M, Sasahara T et al (1998) Serotonin enhances the production of type IV collagen by human mesangial cells. Kidney Int 54:1083-1092
32. Matsumoto K, Sano H, Nagai R et al (2000) Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A. Biochem J 352:233-240
33. Schmidt AM, Hasu M, Popov D et al (1994) Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A 91:8807-8811
34. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M (1994) Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A 91:11704-11708
35. Smedsrad B, Melkko J, Araki N, Sano H, Horiuchi S (1997) Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 322:567-573
36. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H (1991) Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939
37. Jenkins AJ, Velarde V, Klein RL et al (2000) Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49:2160-2169
38. Adler S (1994) Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 5:1165-1172